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The implementation of imaging technologies has dramatically increased the efficiency of preclinical studies,
enabling a powerful, non-invasive and clinically translatable way for monitoring disease progression in real time and
testing new therapies. The ability to image live animals is one of the most important advantages of these
technologies. However, this also represents an important challenge as, in contrast to human studies, imaging of
animals generally requires anaesthesia to restrain the animals and their gross motion. Anaesthetic agents have a
profound effect on the physiology of the animal and may thereby confound the image data acquired. It is
therefore necessary to select the appropriate anaesthetic regime and to implement suitable systems for monitoring
anaesthetised animals during image acquisition. In addition, repeated anaesthesia required for longitudinal studies,
the exposure of ionising radiations and the use of contrast agents and/or imaging biomarkers may also have
consequences on the physiology of the animal and its response to anaesthesia, which need to be considered while
monitoring the animals during imaging studies. We will review the anaesthesia protocols and monitoring systems
commonly used during imaging of laboratory rodents. A variety of imaging modalities are used for imaging
rodents, including magnetic resonance imaging, computed tomography, positron emission tomography, single
photon emission computed tomography, high frequency ultrasound and optical imaging techniques such as
bioluminescence and fluorescence imaging. While all these modalities are implemented for non-invasive in vivo
imaging, there are certain differences in terms of animal handling and preparation, how the monitoring systems are
implemented and, importantly, how the imaging procedures themselves can affect mammalian physiology. The
most important and critical adverse effects of anaesthetic agents are depression of respiration, cardiovascular
system disruption and thermoregulation. When anaesthetising rodents, one must carefully consider if these adverse
effects occur at the therapeutic dose required for anaesthesia, if they are likely to affect the image acquisitions and,
importantly, if they compromise the well-being of the animals. We will review how these challenges can be
successfully addressed through an appropriate understanding of anaesthetic protocols and the implementation of
adequate physiological monitoring systems.
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Introduction
The use of imaging technologies is increasing in biomed-
ical research due to their great scope for non-invasively
studying biochemical and biological processes in the liv-
ing animal. Their application represents a major impact
on the refinement of in vivo studies in animal models, in
particular for allowing longitudinal monitoring of the
onset and the progression of disease within the same
animal, and studying the biological effects of drug candi-
dates and their therapeutic effectiveness. They provide a
very useful set of tools for a more rapid, efficacious and
cost-effective use and characterisation of animal disease
models, with great potential for translational research.
Indeed, small animal imaging is extensively used as a
preclinical experimental tool in many animal models of
human diseases including cardiovascular [1], neurode-
generative [2] and musculoskeletal disorders [3] and
cancer studies [4]. More recently, it has been applied for
the development of stem cell-based therapies [5,6].
There have also been advances wherein researchers are
increasingly using imaging for phenotyping and charac-
terisation of transgenic disease models [7].
The main challenge for in vivo imaging remains the
‘biological motion’ not only regarding the physical re-
strain, but also the respiratory and cardiac activities
affecting the quality of the images. In contrast to human
studies, imaging of small animals generally requires an-
aesthesia which helps to restrain the animals and their
gross motion, but there is still the need to control car-
diac and respiratory motion. During anaesthesia, there is
an inevitable autonomic nervous system depression
which induces cardiovascular and respiratory depression
and induces hypothermia. In addition, other conditions
such as repeated anaesthesia required for longitudinal
studies, the exposure of ionising radiations and the use
of contrast agents and/or imaging biomarkers will also
have consequences on the physiology of the animal and
therefore will need considerations. All these factors will
have a profound effect on the animal’s homeostasis and
may thereby confound the image quality and interpreta-
tions. Therefore, it is important to implement adequate
non-invasive monitoring systems appropriately suited
for the different imaging modalities.
Anaesthesia plays a key role in animal imaging, and
thus, investigators who are planning imaging experi-
ments are required to be familiarised with the multitude
of anaesthesia protocols commonly used for imaging
and the physiological monitoring systems available. Vari-
ous imaging modalities are used for small animal im-
aging, including magnetic resonance imaging (MRI),
computed tomography (CT), positron emission tomog-
raphy (PET), single photon emission computed tomog-
raphy (SPECT), high frequency ultrasound and opticalimaging techniques such as bioluminescence and fluor-
escence imaging. While all these modalities are imple-
mented for in vivo imaging, there are certain differences
in terms of animal handling and preparation for imaging,
how the monitoring systems are implemented and, im-
portantly, how the imaging procedures themselves can
affect mammalian physiology.
We will review the anaesthesia protocols commonly
used in laboratory animals during in vivo imaging, pro-
viding a brief description of the most commonly used
imaging modalities, discussing different anaesthesia
protocols and general procedures associated with the
preparation of the animal (e.g. transport of animals to
imaging facility, acclimatisation period, fasting and diet,
administration of any contrast agent) as well as review-
ing the challenges associated with the implementation
of these physiological monitoring systems during pre-
clinical imaging and how this can be addressed to min-
imise the impact on the well-being of the animals and
its effects on image acquisition and outcome of the
studies.
Imaging modalities: considerations for animal handling
A number of imaging modalities are available for pre-
clinical research, all of them providing a common ad-
vantage of allowing longitudinal non-invasive serial
imaging studies within the same animals and ability to
investigate any anatomical-structural and/or functional
alterations within the tissue/organs of the animal. How-
ever, it is important to understand how the implemen-
tation of these techniques may influence the animal’s
physiology and its handling during imaging. We will
initially revise the particularities of each modality on
the impact of animal handling and its physiological
monitoring (for detailed comparison on preclinical im-
aging technologies, see reviews from Koba et al. [8] and
Kagadis et al. [9]).
CT is an X-ray-based imaging modality in which an X-
ray source and a detector mounted on a gantry rotate
around the specimen to be imaged. The animal is
exposed to multiple X-rays through different angles to
produce three-dimensional (3D) images of the anatom-
ical structures [10]. Currently available preclinical CT
scanners can achieve high resolution with an isotropic
voxel size of as low as a few micrometres (down to 5 to
10 μm), providing good contrast images for mineralised
tissues (bone), but it is poor for imaging other non-
mineralised tissues. However, the use of contrast agents
that are based on heavy elements such as iodine or bar-
ium allows good imaging enhancement of the different
soft-tissue anatomical compartments [11].
CT technology remains extensively used in ortho-
paedic research and also for characterising anatomical
phenotypes in transgenic animals. It is also used for co-
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PET/SPECT modalities and for attenuation correction
for these radionuclide-based techniques.
One of the main challenges of this technology is to
achieve a reasonable resolution and sensitivity in small
field of view within a short acquisition time, accounting
for time that animal is required to be under anaesthesia,
and also to minimise radiation exposure. Most of the
acquisitions should not require high radiation; however,
levels could become critical during high-resolution im-
aging with higher energy X-rays, longer acquisition times
and higher frequency imaging. Small animal CT causes
radiation doses ranging from 70 to 400 mGy [12]. Doses
between 6.5 to 7 Gy are lethal to mice, but even lower
doses have shown biological effects (e.g. stimulation
DNA repair, free-radical detoxification). Therefore,
researchers should be aware of the risk of interference
due to radiation during imaging.
The speed of acquisition is also important when con-
trast agents are used since most of these agents are rap-
idly cleared away from the bloodstream by the kidneys
as rodents typically have a high heart rate (heart rate of
mice ranges between 400 and 600 bpm; in rats, between
250 to 400 bpm compared with 60 to 80 bpm for adult
humans) and a very short circulation time (approxi-
mately 10 s in mice compared with approximately 30 s
in humans). Animal imaging technology is already
implemented with gating-based acquisition systems, in
which image acquisition is acquired simultaneously and
triggered at some predefined physiological signals or
processed post-acquisition. This allows controlling for
the interference effects due to the physiological move-
ment created through the cardiac and respiratory cycle
and has remarkably improved the quality of the images
acquired. Ongoing challenges are focusing on the devel-
opment of ultrafast acquisitions and further improve-
ments on detector sensitivity. The benefits of applying
gating during image acquisitions have been well reported
in micro-CT imaging of rodents [13].
MRI is a non-ionising 3D imaging technique that has
advantages over other methods that use ionising radi-
ation such as CT, SPECT and PET, especially for serial
imaging. This technology uses strong magnetic field to
align the spins of hydrogen nuclei within the tissues and
then the application of pulses of radio waves to system-
atically alter this alignment, causing the hydrogen nuclei
to produce a rotating magnetic field that is detectable by
the scanner. This signal is then manipulated by add-
itional magnetic fields to be digitalized and to build up
enough information to construct an image of the tar-
geted area of the body [14]. Nowadays, preclinical sys-
tems can routinely achieve a resolution of 100 μm in all
dimensions in living animals, providing high-quality ana-
tomical imaging with good structural detail. Moreover,this technology can also provide information on chem-
ical composition (spectroscopy) and other physiological
functional parameters such as blood flow velocity [15].
These techniques are extensively used for anatomical,
functional and physiological characterisations of tissues/
organs in preclinical models.
The ongoing challenges for preclinical MRI are also
related to the relative small anatomical size of rodents
compare to humans; for a mouse image to retain the
same anatomical definition as that achieve in human
images, the acquisition must be with a voxel volume
(3D imaging pixel unit volume) approximately 3,000
times smaller than that of a human and somehow com-
pensating for the signal deficit. The two most import-
ant ways to overcome these problems are by optimising
the radio-frequency coil that surrounds the sample and
elicits and receives the nuclear magnetic signal and by
employing longer acquisition times. Another method to
increase the signal is to work with higher magnetic
fields, and generally, the preclinical systems are work-
ing on the range of 7 to 9.4 T, commonly going up to
11.7 T [14].
The handling of animals and their anaesthesia regimes
becomes challenging when carrying out functional MRI,
in which the response to a stimulus is assessed through
alterations in the animal physiology. In such studies, it is
crucial to maintain the animal within stable and narrow
well-defined physiologic parameters to allow for the crit-
ical detection of a physiologic response associated to the
stimulus. Anaesthesia can markedly affect such func-
tional imaging procedures by affecting the blood flow,
blood oxygenation levels and cardiac and respiratory
functions [16]. The need to use longer imaging times for
some MRI acquisitions represents a major challenge for
these studies, and researchers must ensure that adequate
physiological monitoring is supported with gating sys-
tems to minimise biological motion effects and that the
animal’s homeostasis through the scanning period is
maintained. Because of the high magnetic field, monitor-
ing equipment must be specifically built-in without con-
taining any ferromagnetic material. There are few
suppliers that provide MRI-compatible equipment in-
cluding electrocardiogram (ECG), temperature, blood
pressure and respiration monitoring equipment [17,18].
All the anaesthesia and monitoring equipment used
should not emit radio frequencies that interfere with the
scan. MRI-compatible systems using fibre-optic or
carbon fibre cabling avoid this problem. Main power
supplies can also carry interference through the radio-
frequency screen; therefore, monitoring equipment
should use an adequately filtered and isolated power
source or be battery powered [19].
PET and SPECT rely on the detection of photons
emitted from radiolabelled tracers in the body. SPECT
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emission through collimated detectors rotating around
the animal. Most preclinical SPECT scanners are
equipped with multi-pinhole collimators which allow
acquisitions with higher spatial resolution and sensitivity.
A tomographic data reconstruction is applied, yielding a
3D dataset that can then be manipulated to show any
particular axis of the body [20]. PET systems also detect
gamma rays. The radionuclides emit positrons which
rapidly annihilate with an electron in the tissue while
emitting two photons in opposite directions. The two
simultaneously released gamma rays are registered as
coincidences by external detectors placed around the
subject providing good sensitivity for the detection
of the biotracer with a resolution within the range of 1
to 2 mm.
SPECT systems use radiopharmaceuticals that have a
longer half-life and are widely used in clinics, being more
readily available and less costly than PET tracers, which
require a cyclotron for their production [21]. Neverthe-
less, the high sensitivity of PET tracers and their integra-
tion as biomarkers with multi-capability applications
make them very well suited for small animal imaging
and tracers. Examples of currently used radiomarkers are
18 F-FDG, an analogue of glucose, and 18 F-FLT, a thymi-
dine analogue, which are extensively used as a biomarker
of tissue metabolic activity and inflammation and cell
proliferation, respectively. These techniques provide
great potential to investigate physiological functions,
track metabolic processes and quantify receptor density.
The main limitations of the SPECT preclinical systems
include lower sensitivity and spatial resolution. The PET
systems provide higher sensitivity, with a greater ability
to quantify the tissue concentration of the tracer; how-
ever, the tracers have very short half-life and, as with the
SPECT systems, do not provide anatomical information
of the tissue/organ images. The advantage of both tech-
niques is the high sensitivity in biological systems down
to the picomolar range.
Imaging acquisitions may take up to 2 h, requiring ad-
equate physiological monitoring to maintain good
homeostasis which is crucial for the assessment of func-
tional/metabolic parameters measured through the
radiotracers. Temperature monitoring remains critical
during PET/SPECT acquisitions as the body temperature
strongly confounds the body’s metabolic functions. It is
important to note that vascular access (e.g. cannulation
tail vein) is required to inject the tracer through the gen-
eral circulation to ensure its distribution through the tis-
sues/organs during imaging. Furthermore, to investigate
the kinetics of the tracer uptake, serial blood sampling is
required for extracting an accurate arterial input func-
tion of the tracer used and also for assessing the
integrity of the parent radiolabelled tracer. Suchmeasurement poses a significant challenge in mice be-
cause blood volume is smaller and the heart rate is much
higher in mice than in larger animals or humans. Several
techniques have been proposed such as the use of beta-
probe measurements, microblood sampling, arterial-
venous shunts, factor analysis of dynamic structures and
image-based measurement from a left ventricular region
of interest [22]. The arterial blood sampling in small
amounts at timed intervals is often considered the refer-
ence standard for true blood activity determination.
Animals may get exposed to radiation when imaged
with PET or SPECT. The radiation exposure will de-
pend on the dosage of the tracer injected. The tissue
activity concentration in laboratory rodents is rela-
tively higher than in humans, resulting in higher radi-
ation dose. However, the large surface area compared
to the small body volume of the animals allows for a
larger escape of radiation. PET tracer doses typically
range from 18.5 to 74 MBq (0.5 to 2.0 mCi) for rats
and 1.85 to 7.4 MBq (50 to 200 μCi) for mice. There is
a large variation in organ exposure related to the
radionuclide, biodistribution and clearance of the
compound.
Preclinical optical imaging includes bioluminescence
and fluorescence imaging [23]. Fluorescence imaging
uses external dyes or fluorescent markers which emit
photons after excitation. Fluorescent probes are exten-
sively used and can be found expressed in reporter pro-
teins (GFP, RFP), in microspheres or as dyes that are
widely used for labelling cells or for monitoring gene
expressions. Bioluminescence relies on the production
and emission of light that resulted from an enzymatic re-
action between the luciferase enzyme and its substrate,
luciferin, to produce light. The principal advantage of
in vivo bioluminescence is that the equipment is highly
sensitive and allows the direct detection of low emis-
sions of light, with very little background, yielding a high
signal-to-noise ratio. However, the technique requires
the animal to be injected with the substrate. Fluores-
cence imaging involves no additional animal treatment
but instead requires an external excitation source and
multiple filters to obtain a spectrum of the light emitted
which can compromise the sensitivity as there is a rela-
tively high level of background-emitted light. Reduction
of the autofluorescence is important to enable detection
of weak fluorescent signals, increasing signal sensitivity.
This is generally achieved by minimising skin fluores-
cence using nude animals, avoiding pigmented rodents
and removing the fur around the area of interest. Re-
cently, this has been minimised by the use of infrared
spectrum fluorophores that guarantees acquisition with
less background autofluorescence and also greater tissue
penetration and sensitivity. These techniques are exten-
sively used for monitoring the expression of transgenes,
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apy assessments.
The advantage of these technologies is that they use
low-energy, non-ionising radiation with high sensitivity
down to microns and subpicomolar concentrations.
Moreover, the acquisition times are short, thus minimis-
ing the time that animals are maintained under anaes-
thesia. The main challenges rely on the properties of the
light sources, their wavelength, diffusion and absorption,
which influence the penetration depth of the light into
tissues, as well as the resolution. Also, this technology
has no direct equivalent in the clinics, which compro-
mises the translation of preclinical data.
High frequency ultrasound is based on the propaga-
tion of sound waves through the soft tissues that are
being imaged. The preclinical systems are dedicated
ultrasound systems that use high frequency modes (20
to 50 MHz) to provide good spatial resolution and ad-
equate penetration for anatomical, functional and
hemodynamic real-time information on preclinical mod-
els. These systems are relatively inexpensive and provide
real-time imaging but are limited by the tissue depth
(maximum penetration is around 15 mm) and the struc-
tures (artefacts caused by bone or air) that can be
reached and visualised. This technique is extensively
used in cardiovascular research, prenatal development
and for monitoring tumour growth and metastasis pro-
gression. Acquisitions are generally quick, but it is im-
portant to continue monitoring body temperature,
especially in rodents, to minimise any confounding
effects on the cardiovascular function.
Animal preparation for imaging procedures
Different procedures will be required depending on the
imaging modality that will be used, the tissue/organs to
be imaged and the in vivo experimental protocol
required (e.g. fasting, artery/vein cannulation, ECG
probes, tracheal intubation). All these procedures will in-
fluence the physiological parameters in the animals and
will have to be accounted for when carrying out in vivo
imaging.
Transport of animals and acclimatisation
Animals will have to be transported to the imaging facil-
ity. Such facilities should have an animal housing area to
allow for the acclimatisation of the animals before
imaging and also for monitoring their recovery after the
experimental procedure. Not all the facilities are neces-
sarily fully integrated within a centralised animal unit,
and therefore, it is important that researchers are aware
of the requirements for transporting the animals within
the imaging facilities. These include (1) health screen-
ings to minimise potential disease transfer and (2) accli-
matisation periods to reduce transport stress-relatedresponses for the animals. Furthermore, it is also import-
ant that animals are housed in an area near but sepa-
rated from a procedure room in which all the animal
preparation for imaging (e.g. vein cannulation) is carried
out, as recommended by many codes of practice for the
housing and care of animals used in research.
The standard recovery period after transport for
rodents varies between 2 and 7 days, depending on the
procedure and transport period. In general, it has been
reported that there was an increase of glucocorticoid
concentrations for up to 2 days, decrease in body weight
and immune response suppression of up to 48 h after
transport in rodents [24]. Similarly, a recovery period
should also be considered after imaging, depending on
the type of anaesthetic, the length of anaesthesia and ex-
perimental procedures carried out (e.g. significant blood
volume withdrawal, surgically induced procedure, bone
marrow reconstitution).
Health checks
The health and general conditions of the animal will
affect its physiological response to the anaesthesia and
the outcome of the imaging procedures. Researchers
must be aware that rodents are prey species, so they
may hide or compensate for distress and/or disease con-
ditions to such extent as they appear to be healthily nor-
mal. It is important that, prior to imaging and induction
of anaesthesia, animals are carefully evaluated for good
health. Wherever possible, within the constraints of the
study, animals in good general condition should be used.
This is also important for good experimental study de-
sign as it minimises the variation between individuals,
leading to more accurate, reproducible results and thus
reduction in animal numbers used.
The pre-anaesthetic exam should contain but is not
limited to confirmation of animal’s identification, sex,
age, body weight, body condition, skin condition, esti-
mate hydration, colour of mucous membranes, heart
rate and rhythm, respiratory rate, signs of diarrhoea,
body temperature, evidence of normal food and water
consumption and normal production of urine and faeces
in the cage. Overall, the body condition of the animal is
very important to anaesthesia induction, maintenance
and recovery (e.g. very obese animals may respond
slowly to drugs).
Food withdrawal
Rodents do not require compulsory fasting prior to an-
aesthesia as they do not possess a vomiting reflex. How-
ever, fasting may be required for some imaging
procedures. Fasting can be an effective way to ensure
uniformity of PET imaging with 18 F-FDG (Figure 1), by
decreasing the blood glucose levels associated with food
intake and thus allowing for a more controlled
Figure 1 Example of PET/CT acquisitions showing fasting effects on biodistribution of 18 F-FDG-PET tracer in C57BL/6 mice. (A, B)
Maximum intensity projection, and (A′, B′) two-dimensional coronal view. The fasted animals displayed a more targeted and selective uptake of
the glucose analogue tracer throughout the body, avoiding the general uptake throughout the whole digestive system due to food ingestion.
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body. In rodents, fasting times of up to 6 h are effective
to clear the stomach food [25], but longer fasting periods
will have important detrimental side effects in the ani-
mal conditions including loss of body mass and decrease
of blood glucose and fatty acid levels [26]. Generally,
researchers may fast the animals overnight, removing
the food on the evening prior to the imaging day. How-
ever, Levine and Saltzmann [27] observed loss of body
weight, depletion of liver glycogen, decrease in blood
glucose and loss of amino acids in rats that were starved
overnight and reported that feeding sugar overnight
maintained metabolic homeostasis in rats and is prefer-
able to overnight starvation. If anaesthesia is required
for a pregnant animal, the need to withhold food should
be carefully evaluated.
Rodent food consumption is associated with the ani-
mals’ circadian cycle, and thus, the removal of food over-
night (dark hours) will have a stronger impact on their
caloric intake as compared with that for light hours. It is
important to control the length and timing of fasting be-
fore imaging studies and to ensure that experimentalprotocols are well standardised to ensure the reproduci-
bility between imaging studies. Similarly, it is also very
important to consider the effects of fasting if any specific
dietary requirements are being used and how this can
influence the outcome of the imaging studies (e.g. some
diets can induce strong background autofluorescence in
mice [28]).
Premedication
Premedication refers to the administration of any drugs
in the period prior to induction of anaesthesia. A wide
variety of drugs can be used during the preparation of
animals for imaging studies include the following: anti-
cholinergic drugs which are used to decrease oral and
respiratory secretions, maintain the heart rate and de-
crease gut motility; tranquillisers which are used to re-
lieve anxiety, produce calmness, aid restraint, assist with
a calm postoperative recovery and reduce dose of anaes-
thetic needed; narcotics which are used to sedate an ani-
mal. They reduce the amount of anaesthesia needed,
induce smooth recovery and provide postoperative pain
relief. Other analgesics that may be given are non-
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provide pain relief for up to 24 h after the procedure if
minor surgery has been performed.
Anaesthesia
Anaesthesia is generally required during imaging experi-
ments in order to ensure humane restrain of the ani-
mals. Anaesthesia is described as a state of lack of
awareness of a part or the whole body of the animal
induced by the administration of specific drugs that de-
press nervous tissue activity. It involves a triad effect in-
cluding analgesia (pain relief ), loss of consciousness and
immobilisation (muscle relaxation) [29]. While most of
the imaging procedures are non-invasive, it is very im-
portant to ensure that anaesthetised animals remain in a
stable physiological state with consistent cardiovascular
output, body temperature and blood oxygenation. In-
deed, many studies (e.g. functional MRI) are highly sen-
sitive to these parameters. Therefore, it is very important
to address the physiological effects that different anaes-
thetic regimes are likely to have during imaging.
In order to achieve the effects sought for anaesthesia
in rodents, there is an inevitable autonomic nervous sys-
tem depression which induces cardiovascular depression
(e.g. reduction in cardiac output, blood pressure, altered
blood flow) and respiratory depression (e.g. hypoxia,
hypercapnia, related acidosis) and induces hypothermia,
affecting body metabolism. Moreover, rodents are prey
species with small body size, high body surface/weight
ratio and high metabolic rate which compromises the
pharmacological efficacy of injectable agents and their
body temperature regulation. Consequently, high doses
of agents are required to induce unconsciousness, which
has also a detrimental effect on autonomic depressions.
In this vein, the use of inhalation anaesthesia in rodents
allows these adverse effects to be more controlled due to
their rapid onset and recovery time and low metabolism.
Hence, it is highly recommended to use inhalation an-
aesthesia for imaging purposes.
It is also important to appreciate the variation in re-
sponse to anaesthetics between different animal strains.
Therefore, it is important to reassure and adjust the an-
aesthesia protocol to the particular needs of the strain
and experimental set-up.
Anaesthetic regimes and equipment
Injectable and inhaled anaesthetics are commonly used
in rodents. The latter method is most suitable for im-
aging; due to its rapid onset and recovery times, it allows
a much greater control of the anaesthetic doses and
maintenance times of anaesthesia than when using
injectables. Moreover, inhaled agents are eliminated
quicker via the lungs, whereas injectable agents need to
be metabolised by the liver and excreted by the kidneys[30]. This allows the animals to recover quicker, which is
important in regaining normal physiology to control
post-operative hypothermia and fluid or electrolyte im-
balance. Some of the newer injectable agents have spe-
cific reversal agents which speed recovery and help to
overcome many of these potential problems.
If injectable agents are used for long-term anaesthesia,
as can be the case in MRI acquisitions, there is an in-
creasing risk of developing hypoxia, especially if oxygen
supplementation is not provided, which could lead to re-
spiratory depression and hypercapnia and acidosis if
prolonged.
Injectable anaesthetics. Anaesthetic dose rates for in-
jectable agents will depend on species used, administra-
tion route, age, sex, strain, body condition, environment,
experimental set-up, previous drug treatments and the
level of anaesthesia required. During the initial period of
use, it is important to monitor animals closely and make
any adjustments necessary for future use.
Increasing the length of anaesthesia with a given drug
may require a second or further injection at intervals
during the procedure. However, increasing the initial
dose will result in an increase in depth at the time of
peak action with the risk of reaching a point of an over-
dose. Also, giving intermittent top-up doses of the drug
will cause the depth of anaesthesia to vary considerably.
This may be overcome by administering it as a continu-
ous infusion so that steady plasma concentrations of the
anaesthetic are maintained. However, this can be chal-
lenging depending on the pharmacodynamics of the an-
aesthetic agent and the experimental set-up. In general,
repeated doses will have progressively greater effect and,
in addition to extending the duration of surgical anaes-
thesia, can prolong the sleeping/recovery time following
anaesthesia. This is particularly critical when using
opioids. If the animal does eventually wake up, the re-
sidual effects of the drug may persist for a long period of
time [31].
The two anaesthesia combinations that are widely used
in laboratory rodents are fentanyl-based and ketamine-
based. Agents available are as follows:
1. Fentanyl/fluanisone (Hypnorm™; mostly in
combination with benzodiazepine). Hypnorm™
(tradename) consists of two components: fentanyl
and fluanisone. Fentanyl is a potent, short-term,
opioid agonist analgesic. Fluanisone is a
butyrophenone tranquilliser and is used to suppress
some of the undesirable effects of the narcotic
(fentanyl) such as vomiting and excitement. This
neuroleptanalgesic combination induces moderate
respiratory depression and a poor degree of muscle
relaxation. Hypotension and bradycardia may also be
noted.
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UK) is licensed for sedation in rodents, rabbits and
guinea pigs. As there is poor induction of muscle
relaxation, it cannot be used on its own for surgical
procedures. Fentanyl/fluanisone in combination with
benzodiazepine (midazolam or diazepam) is licensed
for surgical anaesthesia in rodents, rabbits and
guinea pigs. This combination reduces the dose of
Hypnorm™ by 50% to 70%, and benzodiazepine
produces good muscle relaxation. The most
commonly used benzodiazepine tranquilliser is
midazolam (Hypnovel™) as it is water soluble.
Depending on the animal’s depth and length of
anaesthesia, a ‘top-up’ administration may be
necessary. While the effects of midazolam or
diazepam can last for several hours, anaesthetic
duration is lengthened in the first instance by giving
additional Hypnorm™. However, due to
enterohepatic recirculation of the metabolised
anaesthetic products, a relapse of the anaesthesia
effects may occur, which means that Hypnorm™/
Hypnovel™ combinations can have a prolonged
recovery time or ‘sleep’ time (average >4 h for
rodents). Monitoring must continue during this
period; the body temperature, maintained. This
combination also appears to sensitise rodents to
auditory stimuli.
2. Ketamine. Ketamine is one of the most commonly
used anaesthetics in the veterinary field, and the
commercially available injectable versions of
ketamine hydrochloride are known as Vetalar™ or
Ketaset™. Ketamine produces a state of ‘dissociative
anaesthesia’ in which there is profound analgesia,
light sedation and muscle rigidity (stage of
catalepsy). It does not depress the central nervous
system (CNS), and thus, reflexes remain intact.
Some side effects are as follows: eyes remain open,
and ophthalmic ointment is recommended; presence
of spontaneous movements and muscles are tense
which causes an initial increase in blood pressure
although there is also a peripheral vasoconstriction.
In contrast to other anaesthetics, ketamine does not
depress respiration or cardiac output [32].
Used on its own, ketamine does not achieve surgical
anaesthesia but is extremely useful when
administered in combination with xylazine,
medetomidine or diazepam for the production of
surgical anaesthesia. Ketamine is contraindicated for
use in animals with renal or hepatic disease [33].
During ketamine recovery, animals are hyper-
responsive and ataxic. Recovery may also be
associated with behaviour alterations [34].
Combinations of ketamine for general anaesthesia
are as follows:a) Ketamine + alpha-2 adrenergic agonist sedatives
(alpha 2s): medetomidine (DomitorW, Pfizer
Animal Health, Tadworth, UK) or xylazine
(RompunW, Animal Bayer Health, Newbury, UK).
Ketamine/alpha-2 combinations are suitable for
surgical anaesthesia but are significantly
hypotensive and can induce profound bradycardia
and respiratory depression. These combinations
provide, on average, 30 min of surgical
anaesthesia. The sedative can be reversed using
the alpha-2 antagonist atipamezole (AntisedanW,
Pfizer Animal Health), but this should not be
given until the ketamine has worn off, at least 30
min after injection. Atipamezole is a highly
specific antagonist for medetomidine but has
some effect in reversing xylazine as well. Note
that the combination of ketamine/
medetomidine + buprenorphine as preoperative
analgesia has proved toxic in rats [35], and
caution is advised when considering this regime,
but this is strain dependent. This adverse effect
has not been observed when buprenorphine is
administered post operatively. Ketamine-xylazine
combinations may affect the brain
haemodynamics, causing a reduction of the
cerebral blood flow and affecting brain
oxygenation which can have confounding effects
on nuclear magnetic resonance perfusion imaging
[36]. Also, ketamine combinations with xylazine
have substantial cardiovascular effects, manifested
by low pulse rates and hypotension [37].
b) Ketamine and benzodiazepine combinations.
Ketamine can also be combined with
benzodiazepines, such as midazolam, to provide
20 to 30 min of light anaesthesia in rodents. The
depth of anaesthesia may only be sufficient to
permit minor procedures to be performed but
could be used for immobilisation. The degree of
respiratory and cardiovascular depression is less
than when ketamine is combined with an alpha-2
agonist.
3. Alfaxalone (Alfaxan). Alfaxalone (AlfaxanW
Vetoquinol UK Ltd, Buckingham, UK) is an
anaesthetic steroid. The fast metabolism of this drug
enables it to be used for long periods of anaesthesia
by continuous infusion in rodents and maintain a
fairly rapid recovery following the last
administration, but it has to be administered
intravenously (i.v.) in rodents [38]. Renal and hepatic
perfusion and respiratory function is well
maintained.
4. Propofol (RapinovetW, DiprivanW). Propofol is an
isopropylphenyl compound that is available for
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glycerol and egg phosphatide. Propofol exerts its
CNS effects via modulation of the gamma-
aminobutyric acid (GABA) channels through
different sites than the barbiturates, steroids or
benzodiazepines. It rapidly induces unconsciousness;
recovery is more rapid and complete with minimal
residual CNS effects compared with thiopentone,
holding good potential as an anaesthetic regime for
functional MRI (fMRI) studies [39]. Its rapid
elimination from the body and lack of cumulative
effects make it particularly suitable for continuous
infusion, either alone for restraint or in combination
(e.g. ketamine, an opioid or isoflurane) for surgical
anaesthesia. However, it does not induce analgesia,
and thus, analgesics should be considered when
painful manipulations or procedures are performed.
Cerebral blood flow, perfusion pressure and
intracranial pressure decrease following propofol
administration [40]. It is a potent respiratory
depressant, and apnoea is common on induction
unless the drug is given slowly.
5. Barbiturates. Barbiturates modulate GABA
transmission, the most common inhibitory
transmitter in the mammalian nervous system,
inducing depression activity in the reticular
formation (necessary for maintenance of
wakefulness). In addition, barbiturates selectively
depress transmission at the sympathetic ganglia,
which may contribute to decreased blood pressure
following their administration. These agents are
highly metabolised by the liver, and metabolites
accumulate in the body over time. Many of these
agents will produce sedation associated with severe
respiratory depression and general anaesthesia as
larger doses are administered. At high doses, these
agents are utilised for euthanasia. Some
barbiturates are caustic substances (high alkaline
pH) when injected into the living tissue and so
must be given intravenously or diluted and given
intraperitoneally (i.p.) (only for pentobarbitone).
Subcutaneous or intra-muscular routes should be
avoided:
a) Pentobarbitone. This is a barbiturate with a
medium length of action that can be given i.p. or
i.v. in a range of species. Its main effect is one of
hypnosis, with poor analgesia and muscle
relaxation except at near lethal dose rates. There
is profound cardiovascular and respiratory
depression particularly in rats. As pentobarbitone
is highly metabolised by the liver and has
cumulative effects, it is not ideal for long-term
anaesthesia.b) Thiopentone and methohexitone. Short-acting
barbiturates are commonly given intravenously;
they have poor analgesic effects yet reasonable
muscle relaxation. Respiratory function is
depressed and may be temporarily suspended
during induction. Recovery from single doses of
thiopentone and methohexital is due to
redistribution of the drug from brain to
non-nervous tissues (fat, primarily viscera and
skeletal muscle). In the case of methohexital,
rapid hepatic metabolism contributes remarkably
to recovery. It induces a transient small decrease
in arterial blood pressure that is compensated
for by an increase in heart rate. Myocardial
depression is minimal and far less than would
occur with volatile inhalants. Thiopental
anaesthesia has minimal effect on the
neurochemical profile in the rat brain but
substantially increases brain glucose content in
the cortex as detected by in vivo 1H MRS [41].
Thiopentone acts as an irritant outside the vein
and can induce perivascular necrosis.
Methohexitone has a shorter half-life and a
rapid metabolism, so it is suitable for long-term
infusion. It is not an irritant outside the vein,
but tremors can occur if given without
premedication.
6. Miscellaneous. The following are the miscellaneous
agents:
a) Chloral derivatives (e.g. chloral hydrate,
α-chloralose) Chloral hydrate is a reliable sedative hypnotic,
but it has poor analgesic properties.
Consequently, it has frequently been used in
combination with some other drugs such as
magnesium sulphate when general anaesthesia
was the desired endpoint [42]. Chloral hydrate
is medium acting (1 to 2 h). Intraperitoneal
administration of chloral hydrate to rats is
associated with paralytic ileus. For this reason,
it is recommended that this agent be only used
for non-recovery procedures [43].
 α-Chloralose is a hypnotic frequently used in
neuroscience experiments [44]. This drug has
no analgesic activity but can be combined with
local or regional anaesthesia (novocaine,
marcaine, bupivicaine), to produce sufficient
tranquilisation and anaesthesia to allow minor
surgical procedures. The duration of action of
α-chloralose is prolonged (8 to 10 h), making
it a possible choice for long-term anaesthesia.
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than a true anaesthetic, with unproven
analgesic potency, it appears that the most
ethically and scientifically acceptable use of
this agent in rodents is to provide long-lasting
anaesthesia for procedures involving no painful
surgical intervention. The primary advantage
of this drug is the minimal cardiopulmonary
depression seen at the normal doses (high
doses can cause severe respiratory depression).
However, it is very irritating to the GI tract,
causing a dynamic ileus if given i.p. and ulcers
if given orally. Therefore i.v. use is the only
route recommended. This drug should not be
used if any other alternative is available. α-
chloralose has been used for fMRI studies
providing consistent and reproducible blood
oxygen level dependent (BOLD) signals, but it
is important to monitor the animal closely
during recovery of anaesthesia [45].b) Urethane. Urethane produces long periods (8 to
10 h) of anaesthesia, has a wide safety margin
and has little effect on normal blood pressure
and respiration. It produces sufficient analgesia
to allow surgical manipulations [46]. However,
the drug should be handled with ‘extreme care’
as it is considered to be cytotoxic, carcinogenic
and immunosuppressive. Due to the potential
hazards to staff, other anaesthetics should be
assessed and an alternative regimen used
wherever possible. Because of its carcinogenic
effects urethane should only be used in
animals that will not recover following
anaesthesia.
c) Tribromoethanol (AvertinW). Tribromoethanol is
widely used as a short anaesthetic agent for embryo-
transfer surgery for the generation of transgenic
mice [47]. Potential side effects such as local
irritation, fibrous adhesions in the abdominal cavity
and mortalities have been reported.
Tribromoethanol has many features of a good
anaesthetic: a wide margin of safety, rapid induction
and recovery, simple route of administration (i.p.),
provides good muscle relaxation and loss of reflex
activity. However, there have been conflicting
reports of toxic side effects [48]. See Table 1 for
summary of properties of injectable anaesthetics.Inhalation anaesthesia. Inhalation anaesthesia is the
method of choice for general imaging protocols for la-
boratory rodents. Highly volatile anaesthetic agents are
transported through a carrier gas to the animals via a
breathing circuit with an integrated vaporizer whichallows regulation of the anaesthetic concentration and
flow into the animal.
Oxygen is most commonly used as the carrier gas for
the inhalation anaesthetic agent. It is supplied in pres-
surised cylinders and delivered via a pressure regulator
to a flow metre that provides adequate flow rates (0.5 to
1.5 l/min) through an integrated vaporiser. The lung
capacity of the animal and to a lesser extent the effi-
ciency of the anaesthesia circuit used will determine the
gas flow rate needed. The circuit is also necessary to re-
move exhaled gases and to provide a method for assist-
ing or controlling ventilation. Non-rebreathing circuits
are usually used in laboratory animals to ensure mini-
mum dead space and resistance. Also, they provide a
known inspired concentration as the fresh gas inlet goes
directly to the animal, allowing for a good regulation of
the anaesthesia concentration in the inspired gases. The
most commonly used anaesthetic circuits for rodents are
the Bain’s co-axial T-piece facemask in which the fresh
gas inflow pipe runs inside the reservoir limb and the
open facemask system. One of the drawbacks of the lat-
ter is that removal of waste anaesthetic gases is difficult
because gas escapes all around the mask, and this could
result in serious health and safety issues for the operator.
 Inhalation anaesthetic agents. Inhaled anaesthetics
are volatile compounds that have specific effects on
the CNS. Different inhalation anaesthetics require
different concentrations to induce and maintain
anaesthesia, each agent differing in potency and
efficacy. The desirable inhalant must produce
complete anaesthesia, provide a rapid induction
and recovery and be safe, non-irritant and non-
explosive.1. Isoflurane and halothane. These are the most
commonly used inhalation anaesthetics in laboratory
animals. These agents are broadly similar in speed of
onset/offset and potency (Table 2). Isoflurane is
extensively used due to the fact that it is minimally
metabolised (<0.17%) by the liver and therefore is
less toxic to the animal’s metabolism as compared
with injectable anaesthetics. However, both agents
can be rapidly fatal if overdosed, and therefore,
animals should be individually induced and
transferred to a lower maintenance percentage
immediately once they are unconscious, i.e. have lost
their righting reflex.
Isoflurane itself has become a preferred general
anaesthetic agent for cardiovascular studies because
it causes less depression of cardiac function than
injectable general anaesthetics [49]. However, it
decreases blood pressure by reducing peripheral
resistance [50]; see Table 2 for further properties.
Table 1 Properties of main anaesthetic agents used in preclinical research: halothane and isoflurane
Agents Advantages Disadvantages Dosing
Halothane Potent anaesthetic Highly metabolised (hepatotoxic) Induction 3% to 4% Maintenance 1%
to 2% (rats and mice)
High therapeutic index Cardiovascular depressant
Rapid induction and
recovery (1 to 3 min)
Moderate hypotension: reduction in
cardiac output and peripheral
vasodilatation)
Adequate muscle relaxation Respiratory depressant
Non-irritant, non-flammable
nor explosive






Decreases arterial blood pressure
(vasodilatation)
Induction 3% to 4% (rats and mice)
Maintenance: 1.5% to 2% (mice)1.5%
to 2.5% (rats)
Rapid induction and recovery More expensive than halothane
Low toxicity and metabolic
activity: highly safe
Strong smell: aversive
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used in human anaesthesia; some offer no
significant advantages over isoflurane for the
majority of procedures while being considerably
more expensive.
Sevoflurane was first synthesised in the late 1960s
but was not developed for approval until 1990 in
Japan because of concerns about degradation with
soda lime (to produce compound A, which can
produce renal toxicity) and release of fluoride ion
during metabolism (which can also produce
nephrotoxicity). Neither of these concerns has been
proven to be clinically important in the human or
veterinary field. It is less soluble than isoflurane,
which means that inductions and recoveries are
even faster. Sevoflurane also appears to be better
tolerated by face mask and chamber induction
because it has low pungency and low airway
irritability. Since sevoflurane is less potent than
isoflurane (minimum alveolar concentration for
sevoflurane is 2.4% for dogs), the doses used are
usually higher than those used for isoflurane.
However, there have been recent reports that
isoflurane and sevoflurane provided an equally
reliable anaesthesia in laboratory mice [51].
3. Nitrous oxide. Nitrous oxide (N2O) is not potent
enough for induction of anaesthesia and is,
therefore, unsuitable for use alone. It is an analgesic,
relaxant and, to a certain extent, tranquilliser.Nitrous oxide has minimal cardiovascular and
respiratory effects. It is generally used in
combination with other volatile agents to reduce the
required concentration of that agent, allowing for
reduction in dose of other agents, reducing costs,
speeding up induction and providing additional
muscle relaxation. However, it is important to be
aware that the oxygen percentage of the inspired gas
is lowered, and there is a risk for ‘second gas effect’,
in which after prolonged anaesthesia, oxygen can be
displaced from the lungs by the nitrous oxide as it is
breathed off, causing diffusion hypoxia and can lead
to suffocation. It is important to supplement with
100% oxygen after N2O is discontinued to protect
against diffusion hypoxia.
4. Diethyl ether. Diethyl ether is occasionally used in
laboratory animals. It is a good analgesia and
promotes muscle relaxation with minimal
respiratory and cardiovascular depression. However,
it is flammable, explosive and aversive, causing
nauseas and vomiting. Most units have prohibited
the use of this agent due to serious health and safety
concerns and the fact that superior anaesthetic
agents are now available.
5. Methoxyflurane. Methoxyflurane is the least volatile
and the most metabolised of the inhalants. It
produces very slow induction and recovery and is
used occasionally in laboratory animals (e.g. useful
for neonatal rodents).
Table 2 Summary of the properties of injectable anaesthetics




Good analgesic effect Cardiovascular and respiratory
depression
10 ml/kg (mouse), 2.7 ml/kg (rat) i.p. mixture
Hypnorm™/Hypnovel™ (midazolam)/water mixture
(1:1:2 volume) (120 to 140 min sleep time)
Hypnorm™ top-up 0.3 ml/kg (mouse), 0.1ml/kg
(rat) i.p. (30 to 40 min sleep time)
Sedative Poor muscle relaxation alone
Possible to top-up for
long-term anaesthesia










Analgesic effects Muscle rigidity +++ unless
combined with other agents.
Ketamine+medetomidine 75 mg/kg+ 0.5 to
1 mg/kg i.p.(Ketamine + xylazine 75 to 100 mg/kg)/
(10mg/kg i.p.)(60 to 120 min sleep time ) (mouse
and rats)Atipamezole 1mg/kg i.p.Light sedation Increases intracranial pressure.
Wide safety margin Recovery often involved with
ataxia and hyper responsiveness.
Can increase blood pressure
Alfaxalone (Alfaxan) Minimal respiratory or
CVS depression
Administration route i.v. (rodents,
cats) or i.m. (primates)
15 to 20mg/kg (mouse), 10 to 12mg/kg (rat) i.v.
(10 to 15 min sleep time after bolus)0.25 to












i.v. use only 26 mg/kg (mouse), 10 to 12mg/kg (rat) i.v.(10 to
15 min sleep time after bolus)2 to 2.5 mg/kg/min
i.v. infusion (long-term, mouse) 0.5 to 1 mg/kg/min
i.v. infusion (long-term, rat)
No analgesic properties
Rapid recovery Severe respiratory depression
Can be used in animals
with hepatic or
renal impairment.
Apnoea can occur after i.v. bolus
Barbiturates
products
Sedative effect No analgesic properties Pentobarbitone, 40 to 50mg/kg i.p. (mouse) (120
to 180 min sleep)
Good hypnotic
effect




Easy to overdose Thiopentone, 30 mg/kg i.v. 15 min sleep (rat)
Metabolites accumulate with time
Caustic substances (thiopentone
only i.v. route)








α-Chloralose Sedative effect No analgesic properties 50 to 60 mg/kg i.p. (rats), 120 mg/kg i.p. (mouse)
(8 to 12 h for non-recovery only)50 mg/kg i.v. bolus





Slow induction and recovery
associated with involuntary
excitement
Minimal CVS and respiratory
depression
Terminal/non-recovery work only
Urethane Suitable for long-term
anaesthesia.
Carcinogenic: only allowed to be
used with special justification
0.8 to 1.3 g/kg i.p. (mouse and rats)Duration of
action 8 to 10 h (non-recovery only)
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Table 2 Summary of the properties of injectable anaesthetics (Continued)





Wide safety margin Local irritation/peritonitis 0.015 ml/g body wt of 2.5% i.p.
Good muscle relaxation Handling and storage safety issues 30 min; supplemental doses of anaesthesia:
minimum of 1/2 of the initial dose up to 1 ml
maximum volume per animalRapid induction and recovery Toxic effects
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While the ideal anaesthetic agent would produce revers-
ible unconsciousness and analgesia with no other
homeostatic effects, the reality is that all anaesthetic
drugs affect other body systems to some extent. The
most important effect of anaesthetic drugs is depression
of respiration, the cardiovascular system and thermo-
regulation. Therefore, one must seriously assess the
therapeutic dose required for anaesthesia, what the like-
lihood is to affect image acquisitions and the outcome of
scientific data acquisition interference during the pro-
cedure. It is also important to clearly understand that
extreme deviations from maintaining normal physiology
during anaesthesia can be life threatening for the animal.
While it is not clearly defined how frequently one
should monitor the animals during anaesthesia, it is ob-
vious that the more invasive the procedure and/or the
longer time under anaesthesia, the more likely it is to
interfere with normal homeostasis and thus greater the
need for monitoring. A general approach is to continu-
ously monitor cardiovascular and respiratory function as
the minimum standard applicable to veterinary anaes-
thesia. Indeed, for laboratory animals, this may require
specialised monitoring equipment.
The position of the animals is also of importance as
physiological parameters can be quite affected by the
bed systems used in different imaging modalities. It is
crucial that the neck and head are well positioned with
the airway maintained well and open at all times, with-
out restricting breathing or/and cardiovascular function,
e.g. to minimise pressing equipment on the thoracic cav-
ity. Body and extremities should be positioned without
restricting the circulation and avoiding any bruising,
strains or avulsion in the body structures.
Generally, the monitoring procedure should cover the
four body systems, namely central and peripheral ner-
vous, respiratory, cardiovascular and musculoskeletal
systems. Basic parameters should include the following:
a. Respiratory rate, depth and character
b. Heart rate, rhythm and pulse intensity
c. Body temperature
d. Colour of mucous membrane, extremities and
capillary refill time (peripheral perfusion)
e. Central nervous system (muscle tone and reflexes)Direct access and visualisation of the animal while
placed in the scanner during imaging can be challenging,
especially for assessing parameters such as capillary refill
and muscle tone and reflexes.
Respiratory system
Respiratory monitoring can be based on clinical observa-
tions, including observation of the chest motion, or
assessed through detection of breathing motion by com-
pressions of a respiratory sensor placed in contact with
the chest. Respiratory motion detection systems are ex-
tensively used during imaging as they are highly compat-
ible with and safe to use for most of the imaging
modalities (Figure 2).
Motion artefacts due to breathing which can seriously
compromise imaging acquisitions can be eliminated
from the acquired images by employing gating techni-
ques, which allow the synchronisation of data collection
with the respiratory cycle. Typically, the largest move-
ment of the diaphragm and abdomen occur between in-
spiration and expiration; thus, selective acquisition
during the still part of the respiratory cycle can be effect-
ive in reducing breathing artefacts.
Other advanced respiratory monitoring systems in-
clude digital systems that can monitor and detect the
changes in gas temperature and/or compositions be-
tween inspiration and expiration at the endotracheal
tube connector or face masks:
1. Capnograph measures the CO2 level through a
highly sensitive infrared spectroscopy CO2 sensor in
the inhaled and exhaled gas, based on the CO2
values in the venous return to the heart and the
effectiveness of breathing. This equipment is a very
good indicator of the respiratory function, providing
continuous measurements of the CO2 levels. The
CO2 levels rise rapidly during the first part of
exhalation and then flatten off. If the pulmonary
function is compromised or there is poor lung
perfusion, the flatten-out phase will disappear. The
level of CO2 at the end of expiration (etCO2) is
normally within a few millimetres of mercury of the
arterial CO2, and it is very useful for assessing
adequacy of ventilation during both spontaneous
and artificial ventilation [52].
Figure 2 Image displaying some of examples of respiratory monitoring equipment. (a) Respiratory sensor (VioHealthcare, Uckfield, UK); (b)
Capnographs used for rodents: (i) type 340 Capnograph system (Harvard Apparatus, Holliston, MA, USA) with specifications for working with
mouse or rats; (ii) MRI adaptable system: V9004 Capnography/Pulse oximeter (Harvard Apparatus); and (iii) PhysioSuite (Kent Scientific Corporation,
Torrington, CT, USA) CapnoScan to measure the end tidal CO2.
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sampling rate can be quite fast and removes
excessive amount of gas from the airway. There are
some adapted capnographs for rodents that utilise
small volumes and are equipped with a pressure
sensor for measuring tracheal pressure and a
pneumotach with differential pressure transducer for
measuring respiratory airflow. These sensors are
mounted directly on the tracheal or intubation
cannula and connected to the control unit to
minimise the dead space. The tracheal pressure and
the respiratory flow are important signals to monitor
mechanical ventilation when using a respirator,
aiding in avoidance of barotraumatic ventilation.
There are several capnographs with specifications
for working with mouse or rats, but unfortunately,
the equipment tend to be not MRI compatible.
There are few MRI adaptable versatile capnographs
on the market which can include pulse oximetry to
measure PO2, PCO2 and fractional inspired oxygen
measurements. (Figure 2).
2. Blood gas analysis. Arterial blood gas analysis is the
gold standard for assessing respiratory function. The
pH, PO2 and PCO2 levels of the blood sample are
measured with specific electrodes and the
bicarbonate concentration is also calculated.
Through these measurements, we can obtain a
detailed picture of the state of the respiratory
system:
 PO2. It is standard for measuring blood
oxygenation; decrease in PO2 is due to
hypoventilation, inspiration of hypoxic gas
mixtures or impaired gas exchange.
 PCO2. Levels of PCO2 are established by the
balance between CO2 production and
elimination. The PCO2 is fairly constant, and the
arterial level is determined by elimination. HCO3− concentration. Base excess and pH
measurements provide information of acid and
base balance. These measurements may be very
relevant when imaging animals with metabolic
disorders which may have acid and base
disturbances.A blood gas analyser is not a routine piece of monitor-
ing equipment, and interpretation of the results requires
knowledge of pulmonary and renal physiology. The
equipment needs to be near the imaging equipment, and
in particular, for the rodents, one of the main limitations
is the volume of blood that can be removed and the fre-
quency of sampling [53]. However, the system provides
invaluable monitoring data for animals used for cardio-
vascular and respiratory research. It is also standard to
use it for functional MRI studies which are based on
measuring changes in the blood oxygenation levels in
microcirculation in the tissues [54,55] (Figure 3).
Cardiovascular system
Basic cardiovascular monitoring includes assessment of
the following:
 Heart rate. This is generally assessed through
palpation of the chest wall or auscultation using a
stethoscope, but during imaging, the animal is
generally placed within a restricted area with limited
access (e.g. imaging platform). Hence, most of the
modalities will have an electrocardiograph system
implanted with specific electrodes adapted for each
imaging modality.
 Pulse. The pulse is generally measured using a
pressure cuff or an oximeter (see below).
 Capillary refill time. It is measured by applying
pressure to a pink extremity or a mucous membrane
(e.g. gums) and by checking the time for pinkness to
re-invade the pressurised whitened areas (1 to 2 s).
Figure 3 Changes in arterial O2 saturation and PO2 and examples of whole pattern activation. (a) Changes in arterial O2 saturation and
PO2 under different O2 gas concentrations during anaesthesia. These parameters can affect the BOLD response during MRI; therefore, it is
important to monitor blood gas levels during such functional MRI studies [54]. (b, c) Example of whole pattern activation in a rat brain erratically
induced by too deep isoflurane anaesthesia. Such a ‘bad’ activation pattern in the whole brain (c) would mask any specific activation due to a
pharmacological and/or sensorial stimulus, and in this case, the time course shows (b) a general decline in signal, and no effect of the challenge
is visible.
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conjunctiva) or hairless extremities.
The following are advanced cardiovascular monitoring
equipment:
1. Electrocardiograph. The ECG monitors the electrical
activity of the heart. With each beat the atria and
ventricles depolarize and repolarise. The
depolarisation and repolarisation are synchronised in
each chamber, and thus, the action potentials from
each fibre summate, producing a signal that is large
enough to be measured at the surface of the body.
The electrical signal is picked up by electrodes,
amplified and displayed on a screen. The ECG is
always measured as the difference in voltage
between two electrodes. Depending upon the
placement of the electrodes, the ECG has different
shapes. If the electrodes are placed on each arm, a
lead I waveform is obtained. Lead II is measured
from the right arm to the left leg, and lead III is
measured from the left arm to the left leg. For
anaesthetic monitoring, the lead configuration is
largely irrelevant because detailed measurements of
the complex heights are not generally needed,
requiring a waveform that contains all the main
components. A lead II type trace, with positive P, R
and T waves, is usually chosen. In theory, only twoelectrodes are needed to record an ECG since it is
the voltage difference between the two electrodes. In
practice, a third ground electrode is needed to reject
interference. Different ECG electrode systems used
in imaging modalities are shown in Figure 4.
The electrocardiogram only monitors the electrical
activity of the heart, and the heart rate is derived
from this. They do not provide information about
the mechanical function of the heart or the state of
the circulation. However, they are important for the
diagnosis and treatment of arrhythmias. They are
useful in critical situations where the blood pressure
has fallen so low that peripheral pulses are not
palpable. During imaging, it is crucial to get a good
signal for the gating systems to work efficiently.
Motion artefacts during MR imaging can be
eliminated or greatly reduced by employing gating
systems during acquisitions of the MR data. By
synchronising MR data collection with the
electrocardiogram, images can be obtained at
specific times during the animal’s cardiac cycle.
2. Pulse oximeter. The pulse oximeter measures arterial
oxygenation. Pulse oximeters are very useful as they
detect arterial hypoxemia that may be related to
problems that occur in anaesthesia such as
hypoventilation, airway obstruction and equipment-
related problems. Hypoxia is a common and serious
problem, and a pulse oximeter will detect
Figure 4 ECG electrodes systems. (a) System BioVet™ (©m2m Imaging Corp, Newark, USA): the carbon fibre electrodes are applied directly in
contact with the cleaned and shaved chest skin and applied with gel electrode so that a minimal impedance electrical connection is made with
the electrode. (b) Model 1025 small animal monitoring and gating system (Small Animal Instruments, Inc., Stony Brook, NY, USA): the ECG system
used for the MRI scanners uses sub-dermal needle electrodes, pads or surface electrodes. The placement of the electrodes is typically in or on the
right forepaw and the left hind pore, or electrodes are placed in the forepaw as long as it is across the heart plane. All the wire bundles within
the scanner should be taped to eliminate unwanted movement from the gradient vibration and/or air flow. (c) Schematic representation of the
fMRI setting: all the equipment needs to be non-ferromagnetic, and it is connected to a module system which allows gated acquisition of
images, avoiding interferences from motion due to breathing and /or heart beating. Body temperature is also regulated through a heating
module (small rodent heater system; Small Animal Instruments, Inc.) to monitor and control the animal temperature during imaging. The system
software continuously processes the temperature measurements and sends an optical control signal to the heater control module. The rate of
change of temperature is monitored, and heater control is adjusted to regulate temperature changes. Mouse temperature variations of less than
±0.1°C can typically be obtained during magnetic resonance (MR) examination.
Tremoleda et al. EJNMMI Research 2012, 2:44 Page 16 of 23
http://www.ejnmmires.com/content/2/1/44
Tremoleda et al. EJNMMI Research 2012, 2:44 Page 17 of 23
http://www.ejnmmires.com/content/2/1/44hypoxemia long before the animal becomes
cyanosed. The pulse oximeter consists of a probe, a
light-emitting diode and a photo-detector, which can
be applied above a superficial vessel such that the
light is transmitted across the tissues. The emitted
light alternately transmits red light at two different
wavelengths (in the visible and infrared regions)
which are absorbed to different degrees by
oxyhaemoglobin and deoxyhaemoglobin. The
intensity of transmitted light reaching the photo-
detector is converted to an electrical signal. This
information is processed, and the absorption due to
the tissues and venous blood, which is static, is
subtracted from the best-to-beat variation to display
the peripheral oxygen saturation both as a wave
form and a digital reading. The waveform can also
be interpreted to give a reading of heart rate. Strictly
speaking, the pulse oximeter relies on and therefore
gives information about both circulatory and
respiratory systems.
For laboratory animals, the light sensor clips have
been adapted to be placed onto the animal’s thigh,
foot, neck (mostly for mice) or tail for rats and
larger rodents (Figure 5), and assesses the colour of
arterial blood close to the surface. The system
provides real-time continuous measurements of
arterial O2, saturation, pulse strength, breath rate,
blood flow and effort to breathe.
The absolute accuracy of pulse oximeters seems to
be a little lower for animals than for humans [56],
but the trends are still important, and overall, this
equipment is a very valuable tool for monitoring
animals. In general, a saturation of >95% is good. If
it falls to <90%, then the anaesthetist should take
note, but corrective action may not be necessary,
especially if the cause is known and self-limiting.
When the saturation falls below <80%, action should
be taken to improve oxygenation. Some pulseFigure 5 Images displaying the clip sensors used by the pulse oximet
foot in rat. The MouseOxW murine pulse oximeter system from Starr Life Sc
saturation, pulse rate, respiration and pulse and breathe distension. (c) Prof
at 100% and 21% O2 during inhalation anaesthesia with isoflurane.oximeter systems are also MRI compatible with
adapted non-ferrous-magnetic clips and cables for
monitoring animals while imaged in small bore
preclinical MRI scanners [57] (Figure 5).
3. Blood pressure. The blood pressure measurement is
one of the best methods to monitor the
cardiovascular system during anaesthesia [58]. The
mean arterial pressure (MAP) is the best indicator of
how well tissues are perfused. As the MAP falls, vital
organ auto-regulation and perfusion is lost. The
susceptibility of tissues to poor circulation varies
tremendously depending upon their metabolic rate.
The MAP in anaesthetised mice drops is around
80 ± 10 mmHg [59], with average systolic pressures
of 112 ± 10 and mean diastolic pressures of 42 ± 12
mmHg. Combinations of injectable anaesthetics
such as ketamine and xylazine induce marked
decrease of the MAP and the pulse rate [37].
Similarly, isoflurane also has coronary vasodilatation
properties and thus can alter blood flow parameters
in rodents [60]. Therefore, blood pressure
monitoring remains a very important process
especially when undertaking functional MRI studies
[61] or when assessing the perfusion of radiotracers
through specific tissue/organs during PET/SPECT
imaging.
There are two basic methods for measuring arterial
blood pressure, direct and indirect. The direct blood
pressure measurement involves placing a catheter in an
artery and connecting it to a transducer. In rodents, this
procedure is invasive as the artery, femoral or carotid
generally has to be exposed surgically. Once the catheter
has been placed in the vessel and secured, it is either
connected to a pressure transducer via a fluid-filled line
or can be directly connected through the use of indwel-
ling catheters and pressure sensing transducers [62]. For
the fluid filled systems, specific small lines are used forer systems. (a) In the base of the mouse or (b) in the centre of the
iencesW Corp. (Oakmont, PA, USA) provides measurements of O2
ile of arterial O2 saturation measurement in rat during MRI acquisitions
Figure 6 Several systems available for monitoring blood pressure. They include Millar probes (Millar Mikro-TipW, Millar Sensors Systems,
ADInstruments Ltd., Oxford, UK), fibre optic transducer, (which are most suitable for MRI imaging (e.g. Samba Preclin catheterW; Samba Sensors
AB, Västra Frölunda, Sweden) and pressure transducers (TSD104A blood pressure transducer; Biopac Systems, Inc., Goleta, CA, USA). The
perivascular flow probes (Transonic Systems, Inc., Ithaca, NY, USA) provide good precision blood pressure measurements for small animal vessels
(0.25 mm) without the need to expose the lumen of the vessels, although the procedure still requires surgical exposure of the vessels to localise
and fix the transducer around the vessel wall [64]. Indirect blood pressure method (non-invasive) involves inflating a cuff around the tail which
works as a pressure transducer measuring the blood flow in the tail artery.
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fluid to minimise any site effects on the animal’s homeo-
stasis [26] An alternative system can be used for blood
pressure in conscious mice. It consists of a pulse trans-
ducer and inflatable tail pressure cuff configured for use
with rodents. The system records both the cuff pressure
and pulse transducer signal from the tail artery [63]. Sev-
eral systems available are shown in Figure 6.
Body temperature
Most anaesthetic agents profoundly depress thermoregu-
lation, and laboratory rodents with a high metabolic rate
and large surface area-to-body weight ratio are likely to
suffer hypothermia. This is particularly critical when
anaesthetising mice and can be a source of considerable
mortality; therefore, core temperature monitoring is
highly recommended. Temperature can be monitored
using a digital rectal thermometer or thermocouple;
there are several systems available in the market for all
the imaging modalities. Due to muscle relaxation, rectal
temperature may be up to 1°C less than the core body
temperature. Hypothermia can be treated using anexternal heat source, with several systems available in-
cluding circulating hot water blankets, blowing air sys-
tems, electric pads, bubble wrap or infrared lamps.
Hyperthermia is as dangerous as hypothermia; thus, the
external heat source should not only be ‘thermostatically
controlled’ but should be linked to the core temperature.
It is important to minimise heat losses during the animal
preparation before imaging (e.g. hair removal, alcohol-
based surgical preparation) using regulated heating
pad and/or by covering the animal, in particular, the tail,
and insulating it from a cold surface. If fluid replacement
is required, the isotonic solutions should be warmed
to 37°C.
Colour mucous membrane, capillary refill time and
assessment of the central nervous system awareness
These parameters are generally challenging to assess
during imaging while the animals are placed within the
scanners, which are not accessible to researchers. During
induction of anaesthesia, most animals will become
ataxic, lose their righting reflex and eventually become
immobile. At this depth of anaesthesia, they can easily
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allowed to deepen until such responses to pain are ab-
sent. To assess the depth of anaesthesia, the researcher
can check the muscle tone and the response to reflexes
of the anaesthetized animal. Some other regularly
checked reflexes include the foot pinch stimulus (loss of
the pedal withdrawal response) and assessing the blink
response (palpebral reflex) of the animals.
Long-term anaesthesia and monitoring recovery
Some imaging protocols, in particular for MR imaging,
may require long acquisition times, and thus, the animal
will have to be under anaesthesia for a long time. When
animals are anaesthetised for a long period of time, ad-
verse effects caused by poor technique and/or side
effects of many anaesthetic drugs become more apparent
and increasingly critical for the animal’s well-being and
the experimental outcome. Therefore, it is very import-
ant that all the monitoring procedures abovementioned
are well implemented and thoroughly applied during
long-term imaging.
Anaesthesia can be prolonged by maintaining the ani-
mal on inhalation anaesthesia or by repeating standard
injectable regimes. Metabolites will accumulate in an es-
calating manner, so it is important to assess how this
can interfere with the purpose of the experiment.
To minimise systemic accumulation of anaesthetic
metabolites and detrimental effects of long-term use of
anaesthetic drugs, three regimes are generally used for
long-term anaesthesia:
1) Using minimally metabolised volatile anaesthetic
gases (e.g. isoflurane). There is very little practical
difference between administering an inhalation agent
for 30 min or for 8 h. Once the animal has been
anaesthetised, it will remain anaesthetised if supplied
with an appropriate maintenance concentration of
anaesthetic. After 1 or 2 h, the maintenance
concentration of anaesthetic can usually be reduced;
further reductions may be possible, particularly if
the animal is stable, and no further painful stimulus
is given. The major problems encountered when
using volatile anaesthetics for prolonged periods is
usually due to anaesthetic techniques or equipment
failure. It is essential to select an anaesthetic circuit
with minimal dead space and minimal circuit
resistance: this is particularly critical for the MR
systems in which the gas circuit is generally quite
long to access the animal in the magnet bore.
2) Continuous intravenous infusion with rapidly
metabolised and eliminated agents such as propofol.
There are many problems associated with
prolonging anaesthesia using repeated doses of an
injectable agent at frequent time intervals. Givingintermittent doses of the drug will cause the depth
of anaesthesia to vary considerably, although this
may be overcome by administering it as a
continuous infusion so that steady plasma
concentrations of the anaesthetic are maintained.
However, this will require good monitoring of the
animals, familiarisation with the anaesthetic regime
and the pharmacodynamics of the anaesthetic agent.
Animals will have to be catheterised, and a long
infusion line may be required to reach the animal
while placed inside the scanner during imaging (e.g.
for MRI). In general, repeated doses of anaesthetic
drug will increase the depth and duration of the
anaesthesia state, which could potentially prolong
the recovery time. It is preferable to administer
incremental doses of the drug by intravenous route
as the effects are seen more rapidly, and also, the
dosing/effect can be more accurately adjusted.
Administration by other routes is possible, but the
depth of anaesthesia will vary less predictably.
3) Long-acting injectable anaesthetic agents. An
alternative to administering repeated doses or a
continuous infusion of short-acting agents is to
select an anaesthetic with a prolonged duration of
action (e.g. urethane, α-chloralose).
It is also critical to maintain normal physiology during
long-term anaesthesia. In addition to the general moni-
toring guidelines already mentioned, there are some im-
portant procedures that should be followed to ensure
the homeostasis of the long-term anaesthetised animal:
1) Regular repositioning. To avoid any damage that can
be caused to muscles and nerves by the long-term
immobilised position and/or the adoption of an
abnormal position during long-term anaesthesia, it is
prudent to reposition the animal regularly (every few
hours) to minimise local pressure effects and aid
general circulation. Unfortunately, this may not
always be feasible in some imaging protocols in
which the animal is required to maintain the same
position for the acquisitions. In this case, it is
important to ensure that animals are placed in a
proper imaging bed. The animal can be immobilised,
but excessive pressure should not be placed on it,
and normal physiological movements (e.g. breathing)
should not be compromised.
2) Eye protection. The eyes should be protected both
from exposure keratitis (by regular application of
ophthalmic ointment e.g. Lacrilube) and from retinal
damaged caused by exposure to excessive light
intensity in albino strains.
3) Temperature. Core temperature monitoring and
maintenance is essential during long-term
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with many electrophysiological outcome
measurements. The extremities and tail should be
covered whenever possible.
4) Blood sampling. Blood sampling for blood gases,
electrolytes, pH, haemoconcentration etc. is ideal for
long-term monitoring, and correction for any
abnormality by means of the appropriate electrolyte
administration, but this is not always feasible in
small rodents. However, end tidal capnography
should be used, and the ventilator adjusted to keep
end expired CO2 as near normal as possible. If the
animal is kept at normal hydration and temperature,
its kidneys should maintain normal homeostasis. In
the extreme situation of extensive long-term
anaesthesia (after 24 h), the risk for oxygen toxicity
(muscle fasciculation, convulsion) is increased, and
in this case, the inspired oxygen should be kept
below 40%.
5) Fluid status and urine output. Physiological fluids
such as Hartmann’s (e.g. lactated Ringer’s alternating
with glucose-saline) should be infused in order to
meet the daily fluid requirement and to maintain
urine output at about 1to 2 ml/kg/h and to allow for
respiratory losses. Unfortunately, this may be quite
challenging due to the position of the animal in the
imaging bore and experimentally required blood/
fluid collection.
6) Ventilation. Some studies will require the animal to
be mechanically ventilated. Small animal ventilators
are designed to achieve controlled ventilation of the
animal’s lungs by the application of intermittent
positive pressure to the airway, providing the tidal
volume and physiologically relevant respiratory
rates. During mechanical ventilation, the ventilator
applies a positive pressure to the anaesthetic gases to
overcome airway resistance and elastic recoil of the
chest, and flow occurs into the lungs (as compared
to the negative intrathoracic pressure that draws air
in during spontaneous ventilation). The technique is
usually referred to as intermittent positive pressure
ventilation. In both, spontaneous and mechanical
ventilation expiration occurs by passive recoil of the
lungs and chest wall.
When using the ventilator, it is important to set the
right parameters for the animal species and size,
accounting for the following: the breathing rate, the
maximum inspiratory pressure and/or volume and the
inspiratory-to-expiratory ratio (usually set at a 1:1 or
1:2). The latter can be increased to 1:3 or 1:4 to induce
less cardiac depression, while maintaining inflation
pressure below 15 cm H2O. This is because cardiac
output is decreased when the thoracic pressure ispositive (i.e. during inspiration when mechanically
ventilated).
It is important to understand that mechanical ventila-
tion reverses natural breathing, with important effects
on thoracic haemodynamics and also overrides auto-
nomic reflex control of breathing, which normally main-
tains blood gas homeostasis. When monitoring a
ventilated animal, it is important to realise that carbon
dioxide is the main stimulus for respiration and that, if
the arterial carbon dioxide level is reduced below 30 to
35 mmHg, the animal will not attempt to breathe. A
common mistake is to under-ventilate so that the animal
fights the ventilator; this may be misinterpreted as the
animal being not deep enough under anaesthesia and
more anaesthetic is given. The end result is a hypercap-
nic animal that is too deeply anaesthetised. Ideally, one
should have oxygen/carbon dioxide monitoring equip-
ment (e.g. pulse oximeter, end tidal capnograph). The
ventilation settings can then be adjusted to try to main-
tain physiological levels of O2/CO2. Blood gas and elec-
trolyte analysis are useful but confer intermittent
monitoring, and a local analyser is needed. If the ani-
mal’s kidneys are functioning normally, (i.e. not shut
down due to dehydration, blood or heat loss), the animal
can maintain its blood electrolyte, and acid and base bal-
ance, provided that the ventilation rate is adjusted to
maintain the CO2 level. For long-term protocols, this
may involve fluid infusion. For long-term mechanical
ventilation, it may be worth considering humidifying the
inspired gas mix to minimise airway drying and irrita-
tion. Regular tracheal aspiration may be needed to re-
move respiratory tract exudates from the endotracheal
tube in larger laboratory animal species, or alternatively,
an anti-muscarinic agent such as atropine could be
incorporated as a premedication.
Recovery
Monitoring should be carried out until the animal has
fully recovered and there is confidence that all essential
physiological functions are well recovered, in particular,
normal respiratory and cardiovascular function, body
temperature and general behaviour. It is very important
to carry out such assessments before the animal is trans-
ferred back to its housing cage.
 Assessment of peripheral perfusion. Assessment of
peripheral perfusion through the colour mucous
membrane and capillary refill time since perfusion
decreases with anaesthesia. If the colour of the
mucous membranes is pale or cyanotic, it is
important to check the cardiovascular and
respiratory systems as abovementioned. Excessive
loss of fluids through bleeding or evaporation if a
body cavity is surgically opened will rapidly lead to
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turn will affect the function of many organs in a
manner that could have an impact on research data.
If substantial fluid loss is anticipated, calculation of
fluid replacement requirements can be estimated by
weighing the animal before and after the procedure.
Lost fluids can be replaced using solutions such as
0.9% saline or lactated Ringer’s solution, preferably
warmed to 37°C and administered subcutaneously
or intraperitoneally.
 Assessment of central nervous system awareness. This
is important for assessing the depth of the
anaesthesia and, in particular, the level of
consciousness and immobilisation/responsiveness of
the anaesthetised animal during recovery. After
administration of some anaesthetic agents, especially
injectable agents, animals may become ataxic, show
poor coordination and poor reflex response,
especially on the back limbs during the recovery,
and therefore, it is important that they are
monitored closely until they gain normal behaviour.
During recovery, it is important to maintain the core
temperature of the animal, placing the animals on their
right side or in sternal recumbency, in a warm recovery
cage with no sawdust or suchlike bedding that may be
inhaled. If the animals have been under anaesthesia for a
relatively long time, it may be worth considering to sup-
ply oxygen and fluids and nutrition supplement (oral or
parenteral support e.g. high-energy moist foods such as
nutrient agar, jelly or crushed rodent pellets mixed with
water) presented in a petri dish or other manner that
does not require the animal to reach up high. Additional
analgesia should be provided if the animal has under-
gone a painful procedure or if there appears to be any
signs of pain. It is very important to assess for any signs
of pain, e.g. guarding (e.g. limping) or licking/rubbing
the affected area, quietness, isolation from the group,
failure to explore, hunched posture, piloerection and
weight loss [64].
Conclusions
Rodent imaging tools permit new investigations to be
made into fundamental biology, and answers to these
queries often reveal a need for more imaging tools with
which to pursue additional new knowledge, that is, new
tools and new findings reinforce each other, leading to
an ever-advancing frontier of new knowledge about
human health and disease obtained through imaging re-
search with rodents. Laboratory rodent imaging is a rela-
tively new field which is expanding very rapidly and
being integrated into a wide variety of biomedical disci-
plines. Therefore, it is important to consolidate sound
protocols for handling, anaesthesia and monitoring theanimals to ensure suitability for all the specific needs of
a wide range of imaging experiments. Obtaining accurate
and consistent images remains one of the major chal-
lenges in preclinical imaging, in particular, for longitu-
dinal studies. Success relies extensively on choosing the
appropriate anaesthetic regime and using suitable moni-
toring equipment to assist in maintaining good homeo-
stasis. While anaesthetic monitoring equipment for
rodent imaging is in its infancy, it is anticipated that this
rapidly advancing field holds great opportunities for
further research and technology development. Indeed,
further refinement of animal handling protocols, imple-
mentation of new anaesthetic regimes and development
in monitoring equipment are needed to maximise
the potential of current preclinical imaging systems,
minimising any confounding effects on the imaging
outcomes and the studied biological processes. It also
represents an important step towards improving
animal welfare and the three Rs’ principles of hu-
mane experimental technique: replacement, refine-
ment and reduction.
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